Health Care Costs

• 

  Subject Areas on Research

  • 'At All Costs': Breast Cancer Patient Responses to Cost Transparency and Communication. 
  • A Causal View of the Role and Potential Limitations of Capitation in Promoting Whole Health System Performance. 
  • A Community-Based Intervention for Managing Hypertension in Rural South Asia. 
  • A Cost Analysis of Universal versus Targeted Cholesterol Screening in Pediatrics. 
  • A Touchy Subject: Can Physicians Improve Value by Discussing Costs and Clinical Benefits With Patients? 
  • A budget impact analysis of telemedicine-based collaborative care for depression. 
  • A change in anticoagulation monitoring improves safety, reduces transfusion, and reduces costs in infants on cardiopulmonary bypass. 
  • A clinical decision and economic analysis model of cancer pain management. 
  • A comparison of neural network models for the prediction of the cost of care for acute coronary syndrome patients. 
  • A comparison of perioperative outcomes in patients with and without rheumatoid arthritis after receiving a total shoulder replacement arthroplasty. 
  • A comprehensive assessment of the cost of multiple sclerosis in the United States. 
  • A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. 
  • A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa. 
  • A cost-minimisation analysis of lobectomy: thoracoscopic versus posterolateral thoracotomy. 
  • A financial analysis of operative facial fracture management. 
  • A longitudinal study on the relationship between weight loss, medical expenditures, and absenteeism among overweight employees in the WAY to Health study. 
  • A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. 
  • A new era for cardiovascular imaging? Implications of the revoked national coverage decision for CT angiography on future imaging reimbursement. 
  • A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation. 
  • A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States. 
  • A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. 
  • A retrospective cohort study to quantify the contribution of health systems to child survival in Kenya: 1996-2014. 
  • Access to care: eye care provider workforce considerations in 2020. 
  • Actualizing Better Health And Health Care For Older Adults. 
  • Acute childbirth morbidity: its measurement using hospital charges. 
  • Addition of price transparency to an education and feedback intervention reduces utilization of inpatient echocardiography by resident physicians. 
  • Adenocarcinoma of the prostate: an expensive way to die. 
  • Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care System 
  • Advance Care Planning Claims and Health Care Utilization Among Seriously Ill Patients Near the End of Life. 
  • Advancing Value-Based Cardiovascular Care: The American Heart Association Value in Healthcare Initiative. 
  • Advancing Value-Based Models for Heart Failure: A Call to Action From the Value in Healthcare Initiative's Value-Based Models Learning Collaborative. 
  • Alternative Payment Models and Associations With Stroke Outcomes, Spending, and Service Utilization: A Systematic Review. 
  • American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association. 
  • American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Delirium Prevention. 
  • American Society of Clinical Oncology guidance statement: the cost of cancer care. 
  • American Thyroid Association Statement on Remote-Access Thyroid Surgery. 
  • An assessment of medical resource utilization and hospitalization cost associated with a diagnosis of anemia in women with obstetrical bleeding in the United States. 
  • An assessment of the health and economic burdens of glaucoma. 
  • An economic evaluation of prolonged mechanical ventilation. 
  • An empirical analysis of cost outcomes of the Texas Medication Algorithm Project. 
  • Analyzing the cost of preventing nonmelanoma skin cancer. 
  • Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients. 
  • Annual direct and indirect health costs of the congenital ichthyoses. 
  • Annual financial impact of well-differentiated thyroid cancer care in the United States. 
  • Annual medical spending attributable to obesity: payer-and service-specific estimates. 
  • Are primary care services a substitute or complement for specialty and inpatient services? 
  • Are supportive care-based treatment strategies preferable to standard chemotherapy in recurrent cervical cancer? 
  • Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study. 
  • Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer. 
  • Assessing the clinical and economic burden of coronary artery disease: 1986-1998. 
  • Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients. 
  • Assessing the potential economic value of health information technology interventions in a community-based health network. 
  • Assessing uncertainty in cost-effectiveness analyses: application to a complex decision model. 
  • Assessment of Spending for Patients Initiating Dialysis Care. 
  • Association Between Dysphagia and Inpatient Outcomes Across Frailty Level Among Patients ≥ 50 Years of Age. 
  • Association Between Exercise Frequency and Health Care Costs Among Employees at a Large University and Academic Medical Center. 
  • Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. 
  • Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults. 
  • Association of Vision Loss With Hospital Use and Costs Among Older Adults. 
  • Association of inpatient vs outpatient onset of ST-elevation myocardial infarction with treatment and clinical outcomes. 
  • Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTION. 
  • Behavioral Health Integration into Primary Care: a Microsimulation of Financial Implications for Practices. 
  • Best clinical practice: guidelines for managing major depression in primary medical care. 
  • Better functional status in American than Canadian patients with heart disease: an effect of medical care? 
  • Beyond costs and benefits: understanding how patients make health care decisions. 
  • Bias, discrimination, and obesity. 
  • Billing and Insurance–Related Administrative Costs: A Cross-National Analysis 
  • Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment. 
  • Breast Cancer Screening and Health Care Costs. 
  • Bringing basic health care to the rural poor. 
  • Burden of childhood rotavirus disease on health systems in the United States. 
  • Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. 
  • Can Innovation in Regulatory Science Address Health Care Cost Burdens? 
  • Can physicians diagnose strengths and weaknesses in health plans? 
  • Cancer outcomes research. 
  • Cancer therapy costs influence treatment: a national survey of oncologists. 
  • Cancer treatment cost in the United States: has the burden shifted over time? 
  • Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs. 
  • Care continuity impacts medicare expenditures of older adults: Fact or fiction? 
  • Case mix controlled service use and expenditures in the social/health maintenance organization demonstration. 
  • Catastrophic acute and long-term care costs: risks faced by disabled elderly persons. 
  • Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence. 
  • Challenges in merging Medicaid and Medicare databases to obtain healthcare costs for dual-eligible beneficiaries: using diabetes as an example. 
  • Changes in Payment Regulation and Acute Care Use for Total Hip Replacement: Trends in Length of Stay, Costs, and Discharge, 1997-2012. 
  • Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. 
  • Characteristics and current practice of parenteral nutrition in hospitalized patients. 
  • Characterizing hospice discharge patterns in a nationally representative sample of the elderly, 1993-2000. 
  • Charges for outpatient rehabilitation: growth and differences in provider types. 
  • Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011. 
  • Chiropractic Use, Health Care Expenditures, and Health Outcomes for Rural and Nonrural Individuals With Arthritis. 
  • Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis. 
  • Clinical Outcomes and Healthcare Utilization Related to Multidrug-Resistant Gram-Negative Infections in Community Hospitals. 
  • Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction. 
  • Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease. 
  • Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty. 
  • Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections. 
  • Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. 
  • Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. 
  • Colorectal cancer: national and international perspective on the burden of disease and public health impact. 
  • Commercial Claims Data Sources: PearlDiver and Individual Payer Databases. 
  • Common comorbidity scales were similar in their ability to predict health care costs and mortality. 
  • Comparative Cost-Effectiveness of Clinic, Home, or Ambulatory Blood Pressure Measurement for Hypertension Diagnosis in US Adults. 
  • Comparative Effectiveness Trials of Imaging-Guided Strategies in Stable Ischemic Heart Disease. 
  • Comparative Effectiveness of Wellness Programs: Impact of Incentives on Healthcare Costs for Obese Enrollees. 
  • Comparative effectiveness research in oncology. 
  • Comparative effectiveness research in oncology: the need for clarity, transparency and vision. 
  • Comparative effectiveness: insights on treatment options for open-angle glaucoma. 
  • Comparing Medical Costs and Use After Laparoscopic Adjustable Gastric Banding and Roux-en-Y Gastric Bypass. 
  • Comparing health care use and costs among new Medicaid enrollees before and during the COVID-19 pandemic. 
  • Comparison of Ambulatory Health Care Costs and Use Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. 
  • Comparison of Downstream Health Care Utilization, Costs, and Long-Term Opioid Use: Physical Therapist Management Versus Opioid Therapy Management After Arthroscopic Hip Surgery. 
  • Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countries. 
  • Completeness of response and quality of life in mood and anxiety disorders. 
  • Complications, reoperation rates, and health-care cost following surgical treatment of lumbar spondylolisthesis. 
  • Comprehensive Support for Family Caregivers: Impact on Veteran Health Care Utilization and Costs. 
  • Comprehensive support of family caregivers: Are there health system cost offsets? 
  • Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. 
  • Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. 
  • Contemporary issues in the management of von Willebrand disease. 
  • Contralateral Prophylactic Mastectomy in the Era of Financial Toxicity: An Additional Point for Concern? 
  • Conversion Total Knee Arthroplasty: A Distinct Surgical Procedure With Increased Resource Utilization. 
  • Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer. 
  • Cost Effectiveness of Childhood Cochlear Implantation and Deaf Education in Nicaragua: A Disability Adjusted Life Year Model. 
  • Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer. 
  • Cost Offset Associated With Early Start Denver Model for Children With Autism. 
  • Cost analysis of myasthenia gravis from a large U.S. insurance database. 
  • Cost and Value in Contemporary Heart Failure Clinical Guidance Documents. 
  • Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. 
  • Cost and health care utilization in ARDS--different from other critical illness? 
  • Cost and quality of life after intestinal transplantation. 
  • Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer. 
  • Cost effectiveness analysis of early zidovudine treatment of HIV infected patients. 
  • Cost effectiveness of a gene expression score and myocardial perfusion imaging for diagnosis of coronary artery disease. 
  • Cost effectiveness of a test to detect metastases for endometrial cancer. 
  • Cost effectiveness of internet interventions: review and recommendations. 
  • Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). 
  • Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya. 
  • Cost of Inpatient Care of Patients With Pemphigus in the United States: Translating Dollars and Cents Into Improved Patient Care. 
  • Cost of Medical Care of Patients with Advanced Serious Illness in Singapore (COMPASS): prospective cohort study protocol. 
  • Cost of patients with primary open-angle glaucoma: a retrospective study of commercial insurance claims data. 
  • Cost of treatment and prevention of Haemophilus influenzae type b disease. An international perspective. 
  • Cost, utilization, and policy of provision of assistive technology devices to veterans poststroke by Medicare and VA. 
  • Cost-Effectiveness Analysis 2.0. 
  • Cost-Effectiveness of Primary Radiation Therapy Versus Radical Prostatectomy for Intermediate- to High-Risk Prostate Cancer. 
  • Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial. 
  • Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients. 
  • Cost-Utility Analysis of Glaucoma Medication Adherence. 
  • Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? 
  • Cost-effectiveness analyses: a basic overview for dermatologists. 
  • Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. 
  • Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders. 
  • Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. 
  • Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. 
  • Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. 
  • Cost-effectiveness of Antenatal Corticosteroid Therapy vs No Therapy in Women at Risk of Late Preterm Delivery: A Secondary Analysis of a Randomized Clinical Trial. 
  • Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals. 
  • Cost-effectiveness of Descemet's stripping endothelial keratoplasty versus penetrating keratoplasty. 
  • Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department. 
  • Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore. 
  • Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis. 
  • Cost-effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT). 
  • Cost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certainty. 
  • Cost-effectiveness of bariatric surgery. 
  • Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration. 
  • Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence. 
  • Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial. 
  • Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial. 
  • Cost-effectiveness of diagnostic strategies for patients with chest pain. 
  • Cost-effectiveness of digital cognitive behavioral therapy (Sleepio) for insomnia: a Markov simulation model in the United States. 
  • Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia. 
  • Cost-effectiveness of improving primary care treatment of late-life depression. 
  • Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy. 
  • Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. 
  • Cost-effectiveness of osteo-odonto keratoprosthesis in Singapore. 
  • Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison. 
  • Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy. 
  • Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. 
  • Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. 
  • Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. 
  • Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States. 
  • Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease. 
  • Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. 
  • Cost-effectiveness of universal cystoscopy to identify ureteral injury at hysterectomy. 
  • Cost-related health literacy: a key component of high-quality cancer care. 
  • Cost-utility analysis of the cochlear implant in children. 
  • Costs Associated With Lobectomy for Lung Cancer: An Analysis Merging STS and Medicare Data. 
  • Costs Five Years After Off-Pump or On-Pump Coronary Artery Bypass Surgery. 
  • Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. 
  • Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement. 
  • Costs and outcomes after cardiac surgery in patients refusing transfusion compared with those who do not: a case-matched study. 
  • Costs and outcomes of hip fracture and stroke, 1984 to 1994. 
  • Costs associated with febrile neutropenia in the US. 
  • Costs associated with multimorbidity among VA patients. 
  • Costs for heart failure with normal vs reduced ejection fraction. 
  • Costs of Cancer Care Across the Disease Continuum. 
  • Costs of a community-based glaucoma detection programme: analysis of the Philadelphia Glaucoma Detection and Treatment Project. 
  • Costs of criminal justice involvement among persons with serious mental illness in connecticut. 
  • Costs of interventional cardiac procedures. 
  • Costs of smoking: a focus on maternal, childhood, and other short-run costs. 
  • Counting the costs of cancer care. 
  • Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis. 
  • Critical pathway for administering high-dose chemotherapy followed by peripheral blood stem cell rescue in the outpatient setting. 
  • Current Policy and Practice for Value-Based Pricing. 
  • DRIVE it home: making the case for prospective economic data collection in randomized clinical trials. 
  • Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy. 
  • Defining the human and health care costs of chronic venous insufficiency. 
  • Demonstration of a sustainable community-based model of care across the palliative care continuum. 
  • Depression is associated with worse outcomes among women undergoing breast reconstruction following mastectomy. 
  • Depressive disorders: treatment patterns and costs of treatment in the private sector of the United States. 
  • Design, implementation, and evaluation of population-specific telehealth nursing services. 
  • Development of a web-based, specialty specific portfolio. 
  • Differences in health care use and outcomes by the timing of in-hospital worsening heart failure. 
  • Differences in one-year health outcomes and resource utilization by definition of prolonged mechanical ventilation: a prospective cohort study. 
  • Diffusion of novel healthcare technologies to resource poor settings. 
  • Direct health care costs of laryngeal diseases and disorders. 
  • Direct medical costs and resource use for treating central and branch retinal vein occlusion in commercially insured working-age and Medicare populations. 
  • Disability and health care costs in the Medicare population. 
  • Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters. 
  • Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study. 
  • Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China. 
  • Disproportionate Use of Inpatient Care by Older Adults With Kidney Stones. 
  • Disproportionate costs and charges for pediatric catheter ablation: supply and demand... or just supply? 
  • Do the Number of Visits and the Cost of Musculoskeletal Care Improve Outcomes? More May Not Be Better. 
  • Do we understand the effects of 'managed care' in ophthalmology? A review and analysis. 
  • Docetaxel chemotherapy in metastatic castration-resistant prostate cancer: cost of care in Medicare and commercial populations. 
  • Does Health Care Utilization Before Hip Arthroscopy Predict Health Care Utilization After Surgery in the US Military Health System? An Investigation Into Health-Seeking Behavior. 
  • Does intent matter? The medical and societal burden of self-inflicted injury. 
  • Does treatment intensity matter in superficial bladder cancer? Consensus, clinical practice, and confounding. 
  • Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective? 
  • Dose response: intelligent rationing by physicians is the first step to a health-care system that society can afford. 
  • Dry eye medication use and expenditures: data from the medical expenditure panel survey 2001 to 2006. 
  • Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery. 
  • Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. 
  • Economic Analysis of Primary Care-Based Physical Activity Counseling in Older Men: The VA-LIFE Trial. 
  • Economic Burden of Dengue Virus Infection at the Household Level Among Residents of Puerto Maldonado, Peru. 
  • Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction. 
  • Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone. 
  • Economic Spillover Effects of Intensive Unpaid Caregiving. 
  • Economic analysis in eye disease. 
  • Economic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patients. 
  • Economic analysis of endovascular repair versus surveillance for patients with small abdominal aortic aneurysms. 
  • Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer. 
  • Economic analysis of randomized, controlled trials. 
  • Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]. 
  • Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. 
  • Economic burden of asthma in Singapore. 
  • Economic burden of congenital athymia in the United States for patients receiving supportive care during the first 3 years of life. 
  • Economic burden of heart failure in the elderly. 
  • Economic burden of herpes zoster among skilled nursing facility residents in the United States. 
  • Economic causes and consequences of obesity. 
  • Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention. 
  • Economic evaluation of ART in resource-limited countries. 
  • Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty. 
  • Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. 
  • Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy. 
  • Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure. 
  • Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial. 
  • Economic impact of syndesmosis hardware removal. 
  • Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs. 
  • Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users. 
  • Economic winners and losers after introduction of an effective new therapy depend on the type of payment system. 
  • Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Fundamentals of economic analysis. 
  • Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Statistical issues in cost-effectiveness analysis. 
  • Effect of Alzheimer disease on the cost of treating other diseases. 
  • Effect of Facility on Operative Costs of Total Ankle Arthroplasties. 
  • Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease. 
  • Effect of a community-based pedestrian injury prevention program on driver yielding behavior at marked crosswalks. 
  • Effect of facility on the operative costs of distal radius fractures. 
  • Effect of health systems context on infant and child mortality in sub-Saharan Africa from 1995 to 2015, a longitudinal cohort analysis. 
  • Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. 
  • Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism. 
  • Effects of Arthroscopy for Femoroacetabular Impingement Syndrome on Quality of Life and Economic Outcomes. 
  • Effects of admission to a teaching hospital on the cost and quality of care for Medicare beneficiaries. 
  • Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast cancer. 
  • Effects of low-dose atrial natriuretic peptide infusion on cardiac surgery-associated acute kidney injury: A multicenter randomized controlled trial. 
  • Effects of medical research on health care and economy. 
  • Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study. 
  • Electroconvulsive Treatment Utilization for the Inpatient Management of Severe Manic Episodes of Bipolar Disorder. 
  • Eliciting benefit-risk preferences and probability-weighted utility using choice-format conjoint analysis. 
  • Eliciting stated health preferences: an application to willingness to pay for longevity. 
  • Emergency room and inpatient use after cardiac pacemaker implantation. 
  • Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology. 
  • End point selection in acute decompensated heart failure clinical trials: economic end points. 
  • End-of-life cost trajectories and the trade-off between treatment costs and life-extension: Findings from the Cost and Medical Care of Patients with Advanced Serious Illness (COMPASS) cohort study. 
  • Epidemiologic Analysis of Elective Operative Procedures in Infants Less Than 6 Months of Age in the United States. 
  • Equivalence of two healthcare costing methods: bottom-up and top-down. 
  • Essential surgery: key messages from Disease Control Priorities, 3rd edition. 
  • Estimated cost of treating myasthenia gravis in an insured U.S. population. 
  • Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach. 
  • Evaluation of the quality of care in congenital heart surgery: contribution of the Aristotle complexity score. 
  • Examining the effect of publishing of bill sizes to reduce information asymmetry on healthcare costs. 
  • Excess costs of hospital care associated with neonatal candidemia. 
  • Expanded criteria donors/high risk recipients is not always cheaper than hemodialysis. 
  • Expanding Access: Cost-effectiveness of Cochlear Implantation and Deaf Education in Asia. 
  • Experiences of health care costs among people with employer-sponsored insurance and bipolar disorder. 
  • Expert estimates of caregiver hours for older Singaporeans with dementia. 
  • Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. 
  • Factors Associated With Head and Neck Cancer Hospitalization Cost and Length of Stay-A National Study. 
  • Factors that determine catastrophic expenditure for tuberculosis care: a patient survey in China. 
  • Family Caregiver Skills Training to Improve Experiences of Care: a Randomized Clinical Trial. 
  • Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. 
  • Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial). 
  • Feeding the Beast. 
  • Financial Burden in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. 
  • Financial Costs and Burden Related to Decisions for Breast Cancer Surgery. 
  • Financial Effect of Unbundling Moderate Sedation from Procedural Codes in Radiology. 
  • Financial Toxicity and Equitable Access to Clinical Trials. 
  • Financial Toxicity of Cancer Care: It's Time to Intervene. 
  • Financial Toxicity: A Common but Rarely Discussed Treatment Side Effect. 
  • Financial burden, distress, and toxicity in cardiovascular disease. 
  • Financial toxicity, Part I: a new name for a growing problem. 
  • Financial toxicity, Part II: how can we help with the burden of treatment-related costs? 
  • Firearm Injury in the United States: An Overview of an Evolving Public Health Problem. 
  • Firearm related injuries amongst children: estimates from the nationwide emergency department sample. 
  • Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. 
  • Forecasts of active life expectancy: policy and fiscal implications. 
  • Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment. 
  • Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. 
  • From Hospital to Home: Impact of Transitional Care on Cost, Hospitalisation and Mortality. 
  • Full disclosure--out-of-pocket costs as side effects. 
  • Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries: A Systematic Review. 
  • Geographic Variations in Healthcare Utilization and Expenditure for Chronic Rhinosinusitis: A Population-Based Approach. 
  • Geriatric evaluation and management units in the care of the frail elderly cancer patient. 
  • Giving birth at a health-care facility in rural China: is it affordable for the poor? 
  • Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease. 
  • Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. 
  • Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer. 
  • Health Care Resource Utilization of High-Frequency Spinal Cord Stimulation for Treatment of Chronic Refractory Low Back Pain. 
  • Health Care Spending and New Persistent Opioid Use After Surgery. 
  • Health Care Utilization and Prescribing Patterns for Adult Eustachian Tube Dysfunction. 
  • Health Services Research. 
  • Health benefits and economic advantages associated with increased utilization of a smoking cessation program. 
  • Health care and human rights: against the split duty gambit. 
  • Health care cost growth among the privately insured. 
  • Health care costs in the last week of life: associations with end-of-life conversations. 
  • Health care costs. 
  • Health care resource use for uterine fibroid tumors in the United States. 
  • Health care utilization following a homeless medical respite pilot program. 
  • Health care utilization of carpenters with substance abuse-related diagnoses. 
  • Health reform and physician-led accountable care: the paradox of primary care physician leadership. 
  • Health service use and outcome: comparison of low charge, integrated, comprehensive services with usual health care. 
  • Health services access and use among older adults in North Carolina: urban vs rural residents. 
  • Health-care expenditures of overweight and obese males and females in the medical expenditures panel survey by age cohort. 
  • Healthcare Cost Trajectories in the Last 2 Years of Life Among Patients With a Solid Metastatic Cancer: A Prospective Cohort Study. 
  • Healthcare Economics of Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage in the United States. 
  • Healthcare academic informatics and IT vendors - A modest proposal for a collaborative focus. 
  • Healthcare cost differences with participation in a community-based group physical activity benefit for medicare managed care health plan members. 
  • Healthcare reform for imagers: finding a way forward now. 
  • Healthcare spending and utilization following antireflux surgery: examining costs and reasons for readmission. 
  • Healthcare technology: physician collaboration in reducing the surgical cost. 
  • Heller myotomy vs Heller myotomy plus Dor fundoplication: cost-utility analysis of a randomized trial. 
  • High economic burden of caring for patients with suspected extraesophageal reflux. 
  • High-deductible health plans and costs and utilization of maternity care. 
  • Home blood pressure management and improved blood pressure control: results from a randomized controlled trial. 
  • Home health and skilled nursing facility use: 1982-90. 
  • How Medicaid and Managed Care Can Support Evidence-Based Treatment in North Carolina That is Informed by Adverse Childhood Experiences. 
  • How Obamacare will impact reproductive health. 
  • How Racism "Gets Under the Skin": An Examination of the Physical- and Mental-Health Costs of Culturally Compelled Coping. 
  • How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical Studies. 
  • How big of a problem is obesity? 
  • How long and how well: oncologists' attitudes toward the relative value of life-prolonging v. quality of life-enhancing treatments. 
  • How much are patients willing to pay to avoid postoperative nausea and vomiting? 
  • How much do persons with Alzheimer's disease cost Medicare? 
  • Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Cystic Fibrosis 
  • Impact of Insurance Provider on Overall Costs in Failed Back Surgery Syndrome: A Cost Study of 122,827 Patients. 
  • Impact of an innovative financing and payment model on tuberculosis patients' financial burden: is tuberculosis care more affordable for the poor? 
  • Impact of remote monitoring on clinical events and associated health care utilization: A nationwide assessment. 
  • Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice. 
  • Impacts of Workplace Health Promotion and Wellness Programs on Health Care Utilization and Costs: Results From an Academic Workplace. 
  • Implementation of a Preoperative Anemia Clinic Utilizing a Minimal Staffing Model. 
  • Implementation of an educational intervention to improve medical student cost awareness: a prospective cohort study. 
  • Implementation of the Maryland Global Budget Revenue Model and Variation in the Expenditures and Outcomes of Surgical Care: A Systematic Review and Meta-analysis. 
  • Implementing a "free" tuberculosis (TB) care policy under the integrated model in Jiangsu, China: practices and costs in the real world. 
  • Implications of changes in households and living arrangements for future home-based care needs and costs for disabled elders in China. 
  • Implications of cost in treatment selection for patients with coronary heart disease. 
  • Implications of early and guideline adherent physical therapy for low back pain on utilization and costs. 
  • Improving care transitions: current practice and future opportunities for pharmacists. 
  • Improving eye care in residential aged care facilities using the Residential Ocular Care (ROC) model: study protocol for a multicentered, prospective, customized, and cluster randomized controlled trial in Australia. 
  • Improving the Process of Enteral Nutrition Preparation With Milk Technicians: Perceptions of Cost, Time, and Quality. 
  • In reference to "Managing superutilizers--staying patient centered is the solution". 
  • Incidence and lifetime costs of injuries in the United States. 
  • Incidence of Musculoskeletal Injury in US Army Unit Types: A Prospective Cohort Study. 
  • Incorporating indirect costs into a cost-benefit analysis of laparoscopic adjustable gastric banding. 
  • Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections. 
  • Incremental and average cost-effectiveness ratios: will physicians make a distinction? 
  • Incremental cost-effectiveness of evidence-based non-surgical weight loss strategies. 
  • Incremental cost-utility analysis of deep anterior lamellar keratoplasty compared with penetrating keratoplasty for the treatment of keratoconus. 
  • Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States. 
  • Inequity in healthcare needs, health service use and financial burden of medical expenditures in China: results from a consecutive household monitoring study in Jiangsu Province. 
  • Influence of Criminal Justice Involvement and Psychiatric Diagnoses on Treatment Costs Among Adults With Serious Mental Illness. 
  • Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment Evaluation. 
  • Influence of medical comorbidity and surgical indication on total elbow arthroplasty cost of care. 
  • Initial and Longitudinal Cost of Surgical Resection for Lung Cancer. 
  • Inpatient burden of juvenile dermatomyositis among children in the United States. 
  • Inpatient costs of specific cerebrovascular events at five academic medical centers. 
  • Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals. 
  • Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia. 
  • Insurance mandates and trends in infertility treatments. 
  • International Comparison of Poststroke Resource Use: A Longitudinal Analysis in Europe. 
  • International differences in evolution of early discharge after acute myocardial infarction. 
  • Internet-based vestibular rehabilitation for adults aged 50 years and over: a protocol for a randomised controlled trial. 
  • Interspinous device versus laminectomy for lumbar spinal stenosis: a comparative effectiveness study. 
  • Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions. 
  • Inverse National Trends in Decompressive Craniectomy versus Endovascular Thrombectomy for Stroke. 
  • Investment in new technology research can save future health care dollars. 
  • Is Burch colposuspension ever cost-effective compared with tension-free vaginal tape for stress incontinence? 
  • Is an Admission for Decompensated Heart Failure Inevitable? 
  • Is bronchial thermoplasty cost-effective as treatment for problematic asthma patients? Singapore's perspective on a global model. 
  • Is early too early? Effect of shorter stays after bypass surgery. 
  • Is proton beam therapy better than standard radiation therapy? A paucity of practicality puts photons ahead of protons. 
  • Is the APOE epsilon4 genotype associated with higher hospital costs among elderly patients? 
  • Is the Economic Impact and Utilization of Imaging Studies for Pediatric Urolithiasis Across the United States Increasing? 
  • Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease. 
  • It's time to have 'the talk': cost communication and patient-centered care. 
  • Laparoscopic colectomy for cancer: an oncologic feasible option. 
  • Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). 
  • Left main stenosis. 
  • Length of Stay, Mortality, Cost, and Perceptions of Care Associated With Transition From an Open to Closed Staffing Model in the Cardiac Intensive Care Unit. 
  • Lessons from India in organizational innovation: a tale of two heart hospitals. 
  • Leveraging observational registries to inform comparative effectiveness research. 
  • Lifetime direct medical costs of childhood obesity. 
  • Local cost structures and the economics of robot assisted radical prostatectomy. 
  • Long-term Cost-effectiveness in the Veterans Affairs Open vs Endovascular Repair Study of Aortic Abdominal Aneurysm: A Randomized Clinical Trial. 
  • Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions). 
  • Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). 
  • Long-term economic growth stimulus of human capital preservation in the elderly. 
  • Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. 
  • Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure. 
  • Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer. 
  • Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). 
  • Longitudinal patterns of cost and utilization of medicare beneficiaries with bladder cancer. 
  • Longitudinal trends in resource use in an incident cohort of open-angle glaucoma patients: resource use in open-angle glaucoma. 
  • Low health literacy and health outcomes: an updated systematic review. 
  • Maintenance of Weight Loss After Initiation of Nutrition Training: A Randomized Trial. 
  • Managed care does not lower costs but may result in poorer outcomes for patients with gestational diabetes. 
  • Managed-Medicare health club benefit and reduced health care costs among older adults. 
  • Management of allergic rhinitis in the working-age population. 
  • Management of chemotherapy-induced neutropenia: measuring quality, cost, and value. 
  • Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic. 
  • Market-Based Solutions to Antitrust Threats-- The Rejection of the Partners Settlement 
  • Massive transfusion exceeding 50 units of blood products in trauma patients. 
  • Measuring costs in multisite randomized controlled trials: lessons from the VA Cooperative Studies Program. 
  • Measuring use and cost of care for patients with mood disorders: the utilization and cost inventory. 
  • Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. 
  • Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. 
  • Medical cost trajectories and onsets of cancer and noncancer diseases in US elderly population. 
  • Medical costs and productivity losses due to interpersonal and self-directed violence in the United States. 
  • Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. 
  • Medical costs of abnormal serum sodium levels. 
  • Medical economics and the assessment of value in cardiovascular medicine: Part I. 
  • Medical utilization and cost outcomes for poststroke veterans who receive assistive technology devices from the Veterans Health Administration. 
  • Medicare cost effects of recent U.S. disability trends in the elderly: future implications. 
  • Medicare costs for neovascular age-related macular degeneration, 1994-2007. 
  • Medicare utilization, screening, and costs among participants in the Southeastern Diabetes Initiative: A population-based evaluation. 
  • Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer. 
  • Medication adherence changes following value-based insurance design. 
  • Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project. 
  • Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. 
  • Mental health care from the public perspective: the Texas Medication Algorithm Project. 
  • Metabolic syndrome: evaluation of pathological and therapeutic outcomes. 
  • Methods for analyzing health care utilization and costs. 
  • Methods for estimating medical expenditures attributable to intimate partner violence. 
  • Money talks, patients walk? 
  • Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis. 
  • Morbidity and healthcare costs of vascular anomalies: a national study. 
  • Morbidity, mortality, and health care costs for patients undergoing spine surgery following the ACGME resident duty-hour reform: Clinical article. 
  • Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. 
  • Multicomponent intervention versus usual care for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: study protocol for a cluster randomized controlled trial. 
  • Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). 
  • Multisite randomized controlled trials in health services research: scientific challenges and operational issues. 
  • National trends in vertebral augmentation procedures for the treatment of vertebral compression fractures. 
  • Navigating the high costs of cancer care: opportunities for patient engagement. 
  • Navigating the rise of high-deductible health insurance: childbirth in the bronze age. 
  • Net economic costs of dementia in Canada. 
  • New horizons in stroke rehabilitation research. 
  • Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults. 
  • Ninety-day and one-year healthcare utilization and costs after knee arthroplasty. 
  • No Changes in Patient Selection and Value-Based Metrics for Total Hip Arthroplasty After Comprehensive Care for Joint Replacement Bundle Implementation at a Single Center. 
  • Non-medical financial burden in tuberculosis care: a cross-sectional survey in rural China. 
  • Nonoperative care to manage the sacroiliac joint. 
  • Novel Approaches to Value Assessment Beyond the Cost-Effectiveness Framework. 
  • Obesity and long-term clinical and economic outcomes in coronary artery disease patients. 
  • On-pump versus off-pump coronary artery bypass surgery: cost-effectiveness analysis alongside a multisite trial. 
  • Oncology Care Model: Short- and Long-Term Considerations in the Context of Broader Payment Reform. 
  • One-year trajectories of care and resource utilization for recipients of prolonged mechanical ventilation: a cohort study. 
  • Oocyte Cryopreservation for Fertility Preservation in Healthy Women. 
  • Operator-specific outcomes. A call to professional responsibility. 
  • Optimal cancer care across the spectrum of life and disease. 
  • Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial. 
  • Orbital fractures: national inpatient trends and complications. 
  • Organ Transplantation in Greece. 
  • Outcomes and Costs for Women After Breast Cancer: Preparing for Improved Survivorship of Medicare Beneficiaries. 
  • Outcomes and cost among Medicare beneficiaries hospitalized for heart failure assigned to accountable care organizations. 
  • Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. 
  • Outcomes and costs within a disease management program for advanced congestive heart failure. 
  • Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). 
  • Outcomes of coronary artery bypass graft surgery in 24,461 patients aged 80 years or older. 
  • Outcomes of percutaneous and paddle lead implantation for spinal cord stimulation: a comparative analysis of complications, reoperation rates, and health-care costs. 
  • Outcomes-Based CV Imaging Research Endpoints and Trial Design: From Pixels to Patient Satisfaction. 
  • Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. 
  • Overpriced technology in radiation oncology. 
  • PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial. 
  • Pancreatic beta-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study. 
  • Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes. 
  • Patient Perspectives on the Financial Costs and Burdens of Breast Cancer Surgery. 
  • Patient experience and attitudes toward addressing the cost of breast cancer care. 
  • Patient time costs associated with sensor-augmented insulin pump therapy for type 1 diabetes: results from the STAR 3 randomized trial. 
  • Patient-centered adherence intervention after acute coronary syndrome hospitalization. 
  • Patients at Risk for Exceeding CJR Cost Targets After Total Ankle Arthroplasty. 
  • Pediatric Price Transparency: Still Opaque With Opportunities for Improvement. 
  • Perspectives on the Costs of Cancer Care: A Survey of the American Society of Breast Surgeons. 
  • Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction. 
  • Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care. 
  • Population-based clinical decision support: a clinical and economic evaluation. 
  • Post-operative opioid pain management patterns for patients who receive hip surgery. 
  • Posttraumatic stress disorder: epidemiology and health-related considerations. 
  • Potential economic benefit of cleft lip and palate repair in sub-Saharan Africa. 
  • Practice patterns in the management of urinary lithiasis. 
  • Practice-Level Variation in Outpatient Cardiac Care and Association With Outcomes. 
  • Precision diagnosis: a view of the clinical decision support systems (CDSS) landscape through the lens of critical care. 
  • Predicting 10-year care requirements for older people with suspected Alzheimer's disease. 
  • Predicting Costs Exceeding Bundled Payment Targets for Total Joint Arthroplasty. 
  • Predicting Opioid Use, Increased Health Care Utilization and High Costs for Musculoskeletal Pain: What Factors Mediate Pain Intensity and Disability? 
  • Predicting costs among medicare beneficiaries with heart failure. 
  • Predicting costs of Veterans Affairs health care in Gulf War veterans with medically unexplained physical symptoms. 
  • Predictors of Hospitalization, Length of Stay, and Cost of Care Among Adults With Dermatomyositis in the United States. 
  • Predictors of high cost after bariatric surgery: A single institution review. 
  • Predictors of hospital bypass for rural residents seeking common elective surgery. 
  • Preoperative Patient Profile in Total Hip and Knee Arthroplasty: Predictive of Increased Medicare Payments in a Bundled Payment Model. 
  • Preoperative screening strategies for bacterial vaginosis prior to elective hysterectomy: a cost comparison study. 
  • Presidential address: physician accountability--winning the public trust. 
  • Prevalence and costs of major depression among elderly claimants with diabetes. 
  • Prevention of low back pain in the military cluster randomized trial: effects of brief psychosocial education on total and low back pain-related health care costs. 
  • Price of Cancer Care and Its Tax on Quality of Life. 
  • Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. 
  • Process Improvement Initiative for the Perioperative Management of Patients With a Cardiovascular Implantable Electronic Device. 
  • Process improvement in surgery. 
  • Professional nursing education in the future: changes and challenges. 
  • Programmed Outcome Research Teams (PORTs) and implications for clinical practice. 
  • Prolonged mechanical ventilation is even more expensive. 
  • Promoting population health through financial stewardship. 
  • Provincial Variation of Cochlear Implantation Surgical Volumes and Cost in Canada. 
  • Provisional stenting strategies: systematic overview and implications for clinical decision-making. 
  • Public Health Impact of the Centers for Medicare and Medicaid Services Decision on Pass-Through Add-On Payments for Drug-Coated Balloons: A Call to Action. 
  • Public health costs for tuberculosis suspects in Wake County, North Carolina, United States. 
  • Public preferences for interventions to prevent emerging infectious disease threats: a discrete choice experiment. 
  • Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services. 
  • Quality assessment of economic analyses in pediatric urology. 
  • Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial. 
  • Quantifiable impact of the contract for health and wellness: health behaviors, health care costs, disability, and workers' compensation. 
  • Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction. 
  • Re-utilization outcomes and costs of minor acute illness treated at family physician offices, walk-in clinics, and emergency departments. 
  • Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation. 
  • Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005. 
  • Reducing Hospital Readmissions via Optimization of Emergency Department Care. 
  • Reducing the global burden of Preterm Birth through knowledge transfer and exchange: a research agenda for engaging effectively with policymakers. 
  • Reductions in human papillomavirus-disease resource use and costs with quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccination: the FUTURE Study Economic Evaluation. 
  • Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs. 
  • Reform should make health the first item of business. 
  • Reforming payments to healthcare providers: the key to slowing healthcare cost growth while improving quality? 
  • Regional versus general anesthesia for carotid endarterectomy: the American College of Surgeons National Surgical Quality Improvement Program perspective. 
  • Relationship between anemia and health care costs in heart failure. 
  • Repeat abdominal computed tomography scans after pediatric blunt abdominal trauma: missed injuries, extra costs, and unnecessary radiation exposure. 
  • Representativeness of Medicare Participants in the Jackson Heart Study for African American Medicare Beneficiaries. 
  • Research on HIV cure: Mapping the ethics landscape. 
  • Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer. 
  • Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation. 
  • Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. 
  • Resource use in the last 6 months of life among patients with heart failure in Canada. 
  • Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). 
  • Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial. 
  • Response to Burns. 
  • Revising a priority list based on cost-effectiveness: the role of the prominence effect and distorted utility judgments. 
  • Revision lumbar surgery in elderly patients with symptomatic pseudarthrosis, adjacent-segment disease, or same-level recurrent stenosis. Part 2. A cost-effectiveness analysis: clinical article. 
  • Risk and healthcare costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer. 
  • Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension. 
  • Risks versus benefits of different types of long-acting injectable antipsychotics. 
  • Risks, costs, and outcomes of cerebrospinal fluid leaks after pediatric skull fractures: a MarketScan analysis between 2007 and 2015. 
  • Robotic surgery in urological oncology: patient care or market share? 
  • Self-referral in medical imaging: a meta-analysis of the literature. 
  • Service costs of caring for adolescents with mental illness in a rural community, 1993-2000. 
  • Service use patterns for adolescents with ADHD and comorbid conduct disorder 
  • Shared medical appointments for patients with diabetes mellitus: a systematic review. 
  • Short-Term VA Health Care Expenditures Following a Health Risk Assessment and Coaching Trial. 
  • Short-term effects of comprehensive caregiver supports on caregiver outcomes. 
  • Should an academic radiation oncologist be allowed to "opt out" of medicare? 
  • Special care units for people with Alzheimer's disease. Only for the privileged few? 
  • Spinal fusion for pediatric neuromuscular scoliosis: national trends, complications, and in-hospital outcomes. 
  • Spinal surgery: variations in health care costs and implications for episode-based bundled payments. 
  • Squeezing the "value" from cost data. 
  • Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. 
  • State Mandatory Paid Sick Leave Associated With A Decline In Emergency Department Use In The US, 2011-19. 
  • State- and payer-specific estimates of annual medical expenditures attributable to obesity. 
  • State-level estimates of annual medical expenditures attributable to obesity. 
  • Statewide costs of health care-associated infections: estimates for acute care hospitals in North Carolina. 
  • Statistical procedures for analyzing mental health services data. 
  • Streamlining and Reimagining Prior Authorization Under Value-Based Contracts: A Call to Action From the Value in Healthcare Initiative's Prior Authorization Learning Collaborative. 
  • Stroke Care Costs and Cost-Effectiveness to Inform Health Policy. 
  • Study protocol for a cohort study of patients with advanced heart failure in Singapore. 
  • Supporting statements and rationale. 
  • Surgery for hip fracture yields societal benefits that exceed the direct medical costs. 
  • Surgery for spinal stenosis: long-term reoperation rates, health care cost, and impact of instrumentation. 
  • Survival among Veterans Obtaining Dialysis in VA and Non-VA Settings. 
  • System-Level Health-Care Integration and the Costs of Cancer Care Across the Disease Continuum. 
  • TEAM-UP for quality: a cluster randomized controlled trial protocol focused on preventing pressure ulcers through repositioning frequency and precipitating factors. 
  • Taking societal cost into clinical consideration: U.S. physicians' views. 
  • Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference. 
  • Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. 
  • Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. 
  • The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations. 
  • The Annual Direct and Indirect Health Care Costs for Patients with Chronic Pruritus and their Determining Factors. 
  • The Chicago Consensus on peritoneal surface malignancies: Standards. 
  • The Cost of Intramedullary Nailing Versus Skeletal Traction for Treatment of Femoral Shaft Fractures in Malawi: A Prospective Economic Analysis. 
  • The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial. 
  • The Cost to Medicare of Bladder Cancer Care. 
  • The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease. 
  • The Effect of Price on Surgeons' Choice of Implants: A Randomized Controlled Survey. 
  • The Effect of an Innovative Financing and Payment Model for Tuberculosis Patients on Health Service Utilization in China: Evidence from Hubei Province of China. 
  • The Effects of Two Workplace Weight Management Programs and Weight Loss on Health Care Utilization and Costs. 
  • The Final frontier. 
  • The Impact of Cost-Effectiveness on Public and Private Policies in Health Care: An International Perspective: Introduction and overview 
  • The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. 
  • The Influence of a Guideline-Concordant Stepped Care Approach on Downstream Health Care Utilization in Patients with Spine and Shoulder Pain. 
  • The Institute of Medicine Report on the Mental Health and Substance Use Workforce for Older Adults: a reflection. 
  • The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada. 
  • The Public Health Burden of Lymphatic Malformations in Children: National Estimates in the United States, 2000-2009. 
  • The Robotic Method of Repairing Dysphagia. 
  • The Role of Physician-Driven Device Preference in the Cost Variation of Common Interventional Radiology Procedures. 
  • The Use of Echocardiography for Pediatric Patients Presenting with Syncope. 
  • The Utility of Basic Metabolic Panel Tests After Total Joint Arthroplasty. 
  • The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. 
  • The author replies. 
  • The burden of Parkinson's disease on society, family, and the individual. 
  • The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF. 
  • The challenge of health care delivery to the elderly patient with cardiovascular disease. Demographic, epidemiologic, fiscal, and health policy implications. 
  • The changing epidemiology of mechanical ventilation: a population-based study. 
  • The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles. 
  • The cost of assisted outpatient treatment: can it save states money? 
  • The cost of clinically significant urinary storage symptoms for community dwelling adults in the UK. 
  • The cost of visual impairment: purposes, perspectives, and guidance. 
  • The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. 
  • The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. 
  • The cost-effectiveness of treating childhood cancer in 4 centers across sub-Saharan Africa. 
  • The costs and benefits of nonoperative management for adult scoliosis. 
  • The costs of fatal and non-fatal falls among older adults. 
  • The costs of schizophrenia. 
  • The danger of reducing reimbursement for psychiatric disorders in late life. 
  • The dynamics of population aging: demography and policy analysis. 
  • The economic burden of anxiety disorders in the 1990s. 
  • The economic burden of chronic cardiovascular disease for major insurers. 
  • The economic burden of major adult visual disorders in the United States. 
  • The economic burden of physical inactivity: a global analysis of major non-communicable diseases. 
  • The economic burden of vision loss and eye disorders among the United States population younger than 40 years. 
  • The economic cost of myopia in adults aged over 40 years in Singapore. 
  • The economic costs to United States hospitals of invasive fungal infections in transplant patients. 
  • The economics of stone disease. 
  • The effect of geriatrics evaluation and management on nursing home use and health care costs: results from a randomized trial. 
  • The effect of hospice on Medicare and informal care costs: the U.S. Experience. 
  • The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. 
  • The effects of optimal perioperative glucose control on morbidly obese patients undergoing bariatric surgery. 
  • The extricable links between health, wealth, and profits. 
  • The health and economic burden of genital warts in a set of private health plans in the United States. 
  • The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006. 
  • The highest utilizers of care: individualized care plans to coordinate care, improve healthcare service utilization, and reduce costs at an academic tertiary care center. 
  • The impact of anaemia and its treatment on employee disability and medical costs. 
  • The impact of increased reimbursement rates under the new cooperative medical scheme on the financial burden of tuberculosis patients. 
  • The impact of minimally invasive parathyroidectomy on the way endocrinologists treat primary hyperparathyroidism. 
  • The impact of new and emerging clinical data on treatment strategies for atrial fibrillation. 
  • The impact of obesity on health care costs among persons with schizophrenia. 
  • The impact of remission duration on the long-term economic burden of acute myeloid leukemia among patients without hematopoietic stem cell transplant in the United States. 
  • The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. 
  • The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care costs associated with cancer chemotherapy. 
  • The impact of treatment-resistant depression on health care utilization and costs. 
  • The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature. 
  • The importance of context in early autism intervention: A qualitative South African study. 
  • The increasing use of robot-assisted approach for hysterectomy results in decreasing rates of abdominal hysterectomy and traditional laparoscopic hysterectomy. 
  • The lifetime medical cost burden of overweight and obesity: implications for obesity prevention. 
  • The longitudinal health economic impact of viral encephalitis in the United States. 
  • The medical costs of gunshot injuries in the United States. 
  • The moral psychology of rationing among physicians: the role of harm and fairness intuitions in physician objections to cost-effectiveness and cost-containment. 
  • The oncology care model and the future of alternative payment models: A gynecologic oncology perspective. 
  • The patient centered medical home. A systematic review. 
  • The relationship of social environment, social networks, and health outcomes in the Seattle Longitudinal Study: two analytical approaches. 
  • The role of community-based and philanthropic organizations in meeting cancer patient and caregiver needs. 
  • The role of psychotherapy in the treatment of depression: review of two practice guidelines. 
  • The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? 
  • The value in musculoskeletal care: summary and recommendations. 
  • The value of diagnostic medical imaging. 
  • Theories explaining racial differences in the utilization of diagnostic and therapeutic procedures for cerebrovascular disease. 
  • Time-Driven Activity-Based Costing in Oncology: A Step in the Right Direction. 
  • Time-Driven, Activity-Based Costing of Presurgical Infant Orthopedics: A Critical Component of Establishing Value of Latham Appliance and Nasoalveolar Molding. 
  • Timing and cost of scaling up surgical services in low-income and middle-income countries from 2012 to 2030: a modelling study. 
  • Timing of physical therapy consultation on 1-year healthcare utilization and costs in patients seeking care for neck pain: a retrospective cohort. 
  • Tips for Analyzing Large Data Sets From the JAMA Surgery Statistical Editors. 
  • Traditional Chinese medicine (TCM) collaborative care for patients with axial spondyloarthritis (AcuSpA): protocol for a pragmatic randomized controlled trial. 
  • Transcatheter Aortic Valve Replacement Versus Aortic Valve Bypass: A Comparison of Outcomes and Economics. 
  • Trauma: prevalence, impairment, service use, and cost. 
  • Treating latent tuberculosis with rifampin: is it the cheaper option? 
  • Treatment costs for youths receiving multisystemic therapy or hospitalization after a psychiatric crisis. 
  • Treatment of intestinal failure: intestinal transplantation. 
  • Treatment participation and medication adherence: effects on criminal justice costs of persons with mental illness. 
  • Treatment patterns and costs associated with sessile colorectal polyps. 
  • Treatment patterns, health care resource utilization, and costs in U.S. patients diagnosed with chronic hepatitis C infection who received telaprevir or boceprevir. 
  • Trend and geographic analysis for traumatic brain injury mortality and cost based on MarketScan database. 
  • Trends in pathological vertebral fractures in the United States: 1993 to 2004. 
  • Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011. 
  • Twenty years of workers' compensation costs due to falls from height among union carpenters, Washington state. 
  • Two hundred consecutive simultaneous pancreas-kidney transplants with bladder drainage. 
  • US hospitalizations and costs for illicit drug users with soft tissue infections. 
  • Underresourced hospital infection control and prevention programs: penny wise, pound foolish? 
  • Understanding Health Economics in Hand Surgery. 
  • Understanding the Costs Associated With Surgical Care Delivery in the Medicare Population. 
  • Understanding the Economic Value of Plastic Surgery to a Health Care System. 
  • Universal Cholesterol Screening in Childhood: A Systematic Review. 
  • Usage and cost of laser trabeculoplasty in the United States. 
  • Use and Cost of Actinic Keratosis Destruction in the Medicare Part B Fee-for-Service Population, 2007 to 2015. 
  • Use of econometric models to estimate expenditure shares. 
  • Use of patient registries and administrative datasets for the study of pediatric cancer. 
  • Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. 
  • Use of well-child visits in high-deductible health plans. 
  • Usefulness and Cost-Effectiveness of Universal Echocardiographic Contrast to Detect Left Ventricular Thrombus in Patients with Heart Failure and Reduced Ejection Fraction. 
  • Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men. 
  • Uterine Fibroids: Burden and Unmet Medical Need. 
  • Utilisation, contents and costs of prenatal care under a rural health insurance (New Co-operative Medical System) in rural China: lessons from implementation. 
  • Utilization and expenditures of veterans obtaining primary care in community clinics and VA medical centers: an observational cohort study. 
  • Utilization of Predictive Modeling to Determine Episode of Care Costs and to Accurately Identify Catastrophic Cost Nonwarranty Outlier Patients in Adult Spinal Deformity Surgery: A Step Toward Bundled Payments and Risk Sharing. 
  • Utilization of spinal cord stimulation in patients with failed back surgery syndrome. 
  • Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data. 
  • VA community-based outpatient clinics: cost performance measures. 
  • VATS versus open surgery for lung cancer resection: moving toward a minimally invasive approach. 
  • Value in Healthcare Initiative: Summary and Key Recommendations. 
  • Variability in blood transfusions after pancreaticoduodenectomy: A national analysis of the University HealthSystem Consortium. 
  • Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. 
  • Vertical integration: hospital ownership of physician practices is associated with higher prices and spending. 
  • Vestibular schwannoma surgical volume and short-term outcomes in Maryland. 
  • Vital Directions For Health And Health Care: Priorities For 2021. 
  • Vital Directions for Health and Health Care: An Initiative of the National Academy of Medicine. 
  • Vital Directions for Health and Health Care: Priorities From a National Academy of Medicine Initiative. 
  • Waste in the US Health Care System-Insights for Vision Health. 
  • We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. 
  • What Contributes Most to High Health Care Costs? Health Care Spending in High Resource Patients. 
  • What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits. 
  • What are people willing to pay for whole-genome sequencing information, and who decides what they receive? 
  • What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial. 
  • What we know is not enough. 
  • What's it worth? Public willingness to pay to avoid mental illnesses compared with general medical illnesses. 
  • Who are the new users of antipsychotic medications? 
  • Who is paying the bills? Health care costs for musculoskeletal back disorders, Washington State Union Carpenters, 1989-2003. 
  • Why It's Not Time for Health Care Rationing. 
  • Will Obesity Treatment Reimbursement Benefit Those at Highest Risk? 
  • Will the future of health care lead to the end of the robotic golden years? 
  • Will the global economic downturn affect prostate cancer care? Pelvic lymphadenectomy as an example. 
  • Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). 
  • Work-related injuries involving a hand or fingers among union carpenters in Washington State, 1989 to 2008. 
  • Workforce Cost Model for Expanding Congenital and Rheumatic Heart Disease Services in Kenya. 
  • Worse outcomes for patients undergoing brain tumor and cerebrovascular procedures following the ACGME resident duty-hour restrictions. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Bradford, William Dalton, Professor of Pathology, Pathology
  • Brown, Gregory, Assistant Professor of Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine
  • Clements III, Dennis Alfred, Professor Emeritus of Pediatrics, Pediatrics, General Pediatrics and Adolescent Health
  • Cohen, Seth Morris, Professor of Head and Neck Surgery & Communication Sciences, Head and Neck Surgery & Communication Sciences
  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • Dement, John McCray, Professor Emeritus in Family Medicine and Community Health, Family Medicine & Community Health,Occupational & Environmental Medicine
  • Gellad, Ziad F., Associate Professor of Medicine, Medicine, Gastroenterology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Mruthyunjaya, Prithvi, Adjunct Associate Professor in the Department of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
  • Muhlbaier, Lawrence H., Associate Professor Emeritus of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Myers, Evan Robert, Walter L. Thomas Distinguished Professor of Obstetrics and Gynecology in the School of Medicine, Duke Cancer Institute
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Olson, Steven Arthur, Goldner Jones Distinguished Professor of Orthopaedic Surgery, Orthopaedic Surgery
  • Orlando, Lori Ann, Professor of Medicine, Medicine, General Internal Medicine
  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Ridley, David Blaine, Professor of the Practice of Business Administration, Duke Science & Society
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Biomedical Engineering
  • Sorenson, Corinna, Assistant Professor in Population Health Sciences, Duke Science & Society
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Zafar, Syed Yousuf, Adjunct Professor in the Department of Medicine, Duke Science & Society
  • Zullig, Leah L, Professor in Population Health Sciences, Medicine, General Internal Medicine